Repaglinide (AG-EE 623ZW) is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.
Molecular Weight:
452.59
Purity:
>99.99%
CAS Number:
[135062-02-1]
Formula:
C27H36N2O4
Target:
PPAR|||Potassium Channel
T1088
* VAT and and shipping costs not included. Errors and price changes excepted